In this study the authors addressed the hypothesis that estrogen (i.e., 1713-estradiol) acts to repress leukocyte ad hesion, The experiments involved comparing leukocyte adhe sion in cerebral venules in vivo, in intact ovariectomized and 1713-estradiol-treated (100 f,Lg/kg/day for I week) ovariecto mized female rats using topical applications of the adhesion promoting drug, phorbol 12-myristate 13-acetate (PMA), Ad herent Rhodamine-6G-Iabeled leukocytes were viewed through a closed cranial window using intravital microscopy/video metry, Leukocyte dynamics were recorded at baseline and after each dose of PMA, The PMA was suffused (1.0 mUmin) at increasing concerftrations (0,01, 0,1, and 1.0 f,LmollL, 15 min utes at each level), A videotape record of each experiment was made for subsequent analysis of leukocyte adhesion, The data showed that the percentage venular area occupied by adherent leukocytes at baseline was significantly greater in the ovariec-
There is extensive evidence that the leukocyte adhe sion and infiltration that occurs after cerebral ischemia and reperfusion can exacerbate neuropathology (Garcia et aI., 1994; Heinel et aI., 1994; luurlink and Sweeney, 1997; Kochanek and Hallenbeck, 1992; Lefer and Lefer, 1996) , Studies have also shown that estrogen, particu larly 1713-estradiol (E2), has protective effects against ischemic neuropathology (Alkayed et a!., 1998; Dubal et aI., 1998; Pelligrino et aI., 1998; Simpkins et aI., 1997; Wang et a!., 1999) , The mechanisms responsible for es trogen-related neuroprotection are not well understood, but they appear to be diverse, First, chronic estrogen tomized compared to the intact and l713-estradiol-treated groups (12,2%, 3.4%, and 4,2% respectively), That relationship was maintained during PMA treatments to the extent that the percentage venular area occupied by adherent leukocytes in creased to 26.4% in the untreated ovariectomized group com pared to 14.4% and 11.3% in the intact and 1713-estradiol treated groups, respectively, In conclusion, the authors found chronic estrogen depletion enhances leukocyte adhesion in the rat cerebral circulation. Estrogen repletion in such animals is accompanied by a significant reduction in leukocyte adhesion, These findings could, at least in part, account for the ischemic brain damage seen in ovariectomized versus intact females, and the restored neuroprotection observed upon 1713-estradiol treat ment reported in earlier studies, Key Words: 1713-estradiol Phorbol 12-myristate 13-acetate (PMA)-Adhesion mol ecules-Endothelial nitric oxide synthase (eNOS), replacement therapy promotes cerebral vasodilation, an action that is seemingly related to upregulation of endo thelial nitric oxide synthase (eNOS). This increases the capacity of the brain to resist the reductions in perfusion accompanying ischemia (Pelligrino et aI., 1998) , Second, estrogen also provides ischemic neuroprotection via per fusion-independent mechanisms (Wang et aI., 1999) . The possibilities for perfusion-independent estrogen-related brain protection include antioxidant actions (Gridley et aI., 1997) , and an antiapoptotic effect (Garciasegura et aI., 1998) . Relevant to this article, estrogen has been reported to reduce leukocyte accumulation in cardiac tis sue after ischemia (Squadrito et a!., 1997) , and in cul tured human umbilical vein (Caulinglaser et aI., 1996) , Whether this effect occurs via direct or indirect actions has not been established. However, an indirect pathway related to eNOS upregulation remains a viable possibil ity. Nitric oxide (NO) has also been linked to repression of leukocyte adhesion during ischemia and reperfusion in different tissues including the brain (Gidday et aI., 1998) and the heart (Fukuda et aI., 1995) ,
In the current study we addressed the hypothesis that estrogen represses leukocyte adhesion in the brain. Therefore, we compared the magnitude of leukocyte ad hesion, as it relates to chronic depletion and repletion of estrogen, in pial venules in vivo under resting and "stimulated" conditions. For the latter we suffused the established adhesion-promoting drug, phorbol 12myristate 13-acetate (PMA) (Okayama et aI., 1999) .
METHODS
The study protocol was approved by the Institutional Animal Care and Use Committee. Twenty-four adult female Sprague Dawley rats (Charles River, Wilmington, MA, U.S.A.l weigh ing 300 to 400 g were used. Rats were divided in three groups: intact females, ovariectomized (OVX) females, and 17(3estradiol (E2l-treated OVX females. Ovariectomies were per formed by the supplier 4 to 6 weeks before the study. The E2 was prepared in dimethyl sulfoxide and 100 ILg/kg/day were administered intraperitoneally for I week before the study. On the day of the study, rats were anesthetized with halothane, tracheostomized, paralyzed with curare and ventilated with 0.8% halothane in 70% N20:30% O2, Femoral arterial and venous catheters were placed for monitoring of mean arterial blood pressure and arterial blood gases, and for drug infusion, respectively. Rats were secured in a head holder in prone po sition to facilitate placement of a closed cranial window. De tails of this procedure are provided in previous publications (Koenig et aI., 1993; Wang et aI., 1994) . Briefly, a 10 mm diameter craniotomy is performed over the skull midline, the underlying dura was carefully removed, and an II mm diam eter acrylic window-outfitted with three ports for inflow, out flow, and intracranial pressure monitoring-was placed and fixed to the skull with cyanoacrylate gel. After window place ment, halothane was discontinued and a bolus of intravenous fentanyl was administered (10 ILg/kg) followed by a mainte nance dose of intravenous fentanyl of 25 ILg/kg/h and ventila tion with 70% N20:30% O2, These conditions were maintained throughout the study. Cannulae were inserted in the ports, and the space under the window was filled with artificial cerebro spinal fluid, which was suffused at a rate of I mL/min and maintained at a temperature of 37°C, Pe02 = 40 to 45 mm Hg, P02 = 50 to 60 mm Hg and pH -7.35. Intracranial pressure was maintained at 5 to 10 mm Hg by adjusting the height of the outflow cannula. Mean arterial blood pressure was continu ously monitored, and rectal temperature was controlled at 37°C. Arterial blood samples were taken for measurement of pH, Pe02, and P02. Those analyses were performed on an ABL 520 Blood Gas System (Radiometer, Copenhagen, Denmark).
Pial venules were viewed through a microscope (Nikon, Fryer Co. Inc., Huntley, IL, U.S.A.) equipped with a color video camera (Sony, Fryer Co. Inc., Huntley, IL, U.S.A.). An epi-illumination system with a mercury lamp was used. Mag nifications of 800x were displayed on a video monitor. Pial venules were localized and precise diameter measurements were made using a calibrated video microscaler (Optech, Imagen Corporation, Trenton, NJ, U.S.A.). Leukocytes were labeled with Rhodamine 6G (200 ILg/mL in 0.9% saline) given initially as an intravenous bolus (1 mL), and followed by con tinuous infusion at a rate of 1 mL/h (Lindauer et aI., 1996) . An appropriate Rhodamine filter set was inserted into the light path and baseline leukocyte dynamics were recorded before suffu sion of the established adhesion-promoting drug, PMA (Sigma, St. Louis, MO, U.S.A.). The PMA was suffused at 1 mUmin at increasing concentrations (0.01, 0.1, and 1.0 ILmollL). Each J Cereb Blood Flow Metab, Vol. 19, No. 10, 1999 dose was maintained for 15 minutes before recording adhesion. In all cases, illumination was limited to 60 seconds at a time to avoid photoquenching. A videotape record of each experiment was made for subsequent analysis of leukocyte adhesion. This analysis was performed by capturing multiple frames of taped images in a computer and measuring the percentage of the venular area occupied by adhering leukocytes using the Image Pro Plus analysis system (Media Cybernetics, Silver Spring, MD, U.S.A.). These images were representative of the dynam ics observed during each step of the experiments. Each experi mental group was divided into 2 subgroups: one subgroup re ceiving PMA and the other used as a time control. For the latter, artificial cerebrospinal fluid was suffused continuously, and leukocyte dynamics were recorded at baseline and after 15, 30, and 45 minutes of suffusion.
Statistical analyses were performed using one way analysis of variance with a post hoc Tukey, repeated measures analysis of variance, and paired t-test. All values are reported as mean ± SD. Statistical significance was considered at P < 0.05.
RESULTS
The arterial blood variables measured at baseline are summarized in Table 1 . There were no significant dif ferences in pH, Po2, Pco2, or mean arterial blood pres sure in any of the three groups and over the course of each experiment regardless of the dose of PMA used. Arterial variables in time control experiments were vir tually the same as those in the PMA studies and re mained constant throughout (data not shown). The range of diameters for the pial venules studied in all experi ments was 35 to 70 fLm. Baseline leukocyte adhesion was considerably greater in the OVX compared to the other groups. The percentage venular area occupied by adhering leukocytes (slow rollers and stickers) was 3.4%, 12.2%, and 4.2% in the intact, OVX, and E2treated OVX females, respectively (Fig. 1) . The values for the OVX group were significantly higher than the values obtained for the other 2 groups. Topical applica tions of PMA, as expected, produced a dose-dependent increase in leukocyte adhesion in all groups. The base line relationships and significant differences among groups were generally maintained during PMA, with the percentage venular area occupied by adhering leukocytes increasing 2.5 to 3 fold from baseline at the highest PMA level to 14.4%, 26.4%, and 11.3% in intact, OVX, and E2-treated OVX, respectively. In the other set of experi ments (time control), the percentage of adherent leuko cytes did not change throughout 45 minutes of suffusion with drug-free artificial cerebrospinal fluid (Fig. 2) . Baseline values were similar to those found in the PMA treated groups. Representative baseline images of pial venules with adherent leukocytes are shown in Fig. 3 .
DISCUSSION
The findings in this study clearly show that (1) chronic estrogen depletion enhances leukocyte adhesion in the cerebral circulation in rats; (2) this effect was reversed by estrogen treatment; and (3) PMA increased leukocyte adhesion in intact, OVX, and E2-treated OYX rats.
Leukocyte rolling and sticking results from interac tions between receptor-ligand pairs on both the leukocyte and the endothelial cell (Hickey and Kubes, 1997; Sharar , 1995) . There are different families of adhesion molecules acting at each step. Leukocyte rolling is me diated primarily by the selectin family of adhesion mol ecules (P-, E-, and L-selectin), as they bind to their re spective counter-ligands (Lasky, 1992) . Subsequent firm adhesion is mediated by the interaction between mem bers of the integrin family, on leukocytes, with adhesion molecules on the endothelial surface (ICAM-I, ICAM-2, VCAM-l). Of particular importance in this step is the stable bond mediated by the (132 integrins LFA-l (CDllalCDl8) and Mac-l (CDllb/CDI8) to ICAM-l (Smith, 1993) . The last step in the adhesion cascade is the leukocyte transendothelial migration, or diapedesis, and involves the participation of an adhesion molecule present in both endothelium and leukocytes (i.e., PECAM-l). The finding that baseline leukocyte adhesion was in creased in OVX rats, and reversed by E2 treatment, sug gests that estrogen acts to repress leukocyte adhesion. The mechanism involved in that action has not been established. It is known, however, that PMA increases leukocyte adhesion through activation of protein kinase C, which results in rapid mobilization of P-selectin from Weibel-Palade bodies in the endothelial cell (Okayama et aI., 1999) . Mobilization of P-selectin, as mentioned above, is an important step in initiating leukocyte rolling in the vessel wall. In this study, the PMA-mediated in crease in leukocyte adhesion was proportional in all groups, but reached higher levels in estrogen-depleted rats. This suggests that estrogen may decrease leukocyte adhesion by modulating expression of adhesion mol ecules. Evidence from cultured human umbilical vein endothelial cells points to a mechanism whereby estro gen inhibits cytokine (interleukin-II3)-mediated endothe lial cell adhesion molecule transcriptional activation. The adhesion molecules modulated by E2 were E-selectin, ICAM-l, and VCAM-l (Caulinglaser et aI., 1996) . In another study, treatment with E2-reduced leukocyte ac cumulation in myocardium, after ischemia and reperfu sion, by reducing ICAM-l (Squadrito et aI., 1997) . A similar mechanism could explain, at least in part, the phenomenon observed in the current study. However, data on cerebral expression of adhesion molecules in estrogen-deprived rats must await further investigation.
There is also compelling evidence that NO, in particu lar eNOS-derived NO, reduces leukocyte adhesion (Lefer, 1997) . The major action of NO, in this regard, apparently is to diminish the expression of adhesion mol ecules, particularly E-selectin, ICAM-l, and VCAM-l (Decaterina et aI., 1995; Kupatt et aI., 1997) . In some instances that effect of NO, like that of E2, may be caused by interference with cytokine-induction mecha nisms. Another possibility is a NO-associated inhibition of NFKB, a transcription factor involved in the regulation of most proinflammatory genes, including adhesion mol- ecules (Collins et a!., 1995; Kupatt et a!., 1997) . Because both E2 and NO have similar effects on adhesion mol ecules, this suggests that, in this model, estrogen may decrease leukocyte adhesion by increasing NO release from the endothelium. This possibility is supported by recent findings that E2 upregulates brain eNOS (as well as neuronal NOS) (Pelligrino et a!., 1998; Wang et a!., 1999) .
In summary, we found that estrogen reduces cerebral leukocyte adhesion in the female rat. Whether estrogen modulates leukocyte adhesion through NO-dependent, or NO-independent mechanisms, remains to be established. Recent findings showing that estrogen decreases isch emic damage, coupled with results indicating that isch emic damage can be exacerbated by leukocyte infiltra tion, suggests that decreased leukocyte adhesion may be an important mechanism in estrogen-mediated neuropro tection.
